About Contact Us Careers

Neuralgia Drugs Market Trends

Request Free Sample Copy

Report ID: 3469
Published Date: Aug 28, 2024
Report Format: PDF, PPT

Buy Now

Neuralgia Drugs Market Trends

Growth Drivers

Growing Prevalence of Trigeminal Neuralgia
Increasing Incidence Rate of Diabetes Around the World

Challenges

Poor Efficacy of Several Available Neuralgia Drugs

Neuralgia Drugs Market: Key Insights

Base Year	2023
Forecast Year	2024–2036
CAGR	6.3%
Regional Scope	North America (U.S., and Canada) Latin America (Mexico, Argentina, Rest of Latin America) Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific) Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe) Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)

Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:

Neuralgia Drugs Market Size, Growth Report 2036

Author Credits: Radhika Pawar

Report ID: 3469
Published Date: Aug 28, 2024
Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Neuralgia Drugs Market size is poised to grow at over 6.3% CAGR during the forecast period i.e., between 2024-2036.

The market growth is impelled by growing prevalence of trigeminal neuralgia and increasing incidence rate of diabetes around the world.

Asia Pacific is poised to dominate majority revenue share by 2036, on the back of increasing occurrence of diabetes and rising elderly population in the region.

The major players in the market are Pfizer, Inc., Novartis AG, Biogen Inc., Cadila Healthcare Limited, Lundbeck Pharmaceuticals LLC, and others.

Inquiry Before Buying Request Free Sample